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Thyroid hormones enter isolated white adipocytes largely by a System L1-type amino acid transporter en route to exerting
genomic actions. Diﬀerentiated 3T3-L1 mouse adipocytes in culture express mRNA for LAT1 (the catalytic subunit of high-
aﬃnity System L1). L-[125I]-T3 uptake into 3T3-L1 adipocytes included a substantial saturable component inhibited by leucine.
L-[3H]phenylalanine uptake into 3T3-L1 cells was saturable (Km of 31μM), competitively inhibited by T3 (Ki of 1.2μM) and
blocked by leucine, BCH, and rT3 as expected for substrate interactions of System L1. Eﬄux of preloaded L-[3H]phenylalanine
from 3T3-L1 adipocytes was trans stimulated by external leucine, demonstrating the obligatory exchange mechanism of System
L1 transport. T3 (10μM) did not signiﬁcantly trans stimulate L-[3H]phenylalanine eﬄux, but did competitively inhibit the trans
stimulatory eﬀect of 10 μM leucine. The results highlight strong competitive interactions between iodothyronines (T3,r T 3)a n d
amino acids for transport by System L1 in adipocytes, which may impact cellular iodothyronine exchanges during altered states of
protein nutrition.
1.Introduction
The thyroid hormones (THs) L-thyroxine and L-triio-
dothyronine are iodothyronines exerting their major physio-
logical eﬀects by regulation of gene expression in target cells,
whichtheymustﬁrstenterbycrossingtheplasmamembrane
[1–3]. Iodothyronines are now known to translocate cell
membranes by a variety of mechanisms, which include the
sharing of transport systems for large neutral amino acids
(LNAAs; principally aromatic and branched-chain amino
acids) and organic anions (see, e.g., [4–6] for review). TH
retain a tyrosine-derived amino acid moiety within the
iodothyronine molecular structure, allowing them to be
accepted as substrates by LNAA transporters such as System
L (notably the “System L1” SLC7A5/SLC3A2 heterodimer
isoform LAT1) [7, 8] and System T (MCT10; SLC16A10)
[9].
White adipose tissue is an important target tissue for
TH action, where eﬀects include stimulation of adipogenesis
itself [10], modulation of fatty acid synthesis via regulation
of expression of lipogenic enzymes [10–12]a n dm o d u l a t i o n
of leptin secretion [13, 14]. TH enter rat adipocytes largely
by a System L1-type amino acid transporter [15]a n dL A T 1
mRNA are expressed in rat adipocytes [16]. System L1
is also likely to be of major importance for amino acid
metabolism in adipose tissue, which is a site of signiﬁcant
BCAA degradation and utilization for fatty acid and sterol
synthesis [17, 18]. The System L1 substrate leucine in
particular appears to be involved in modulation of the
mTOR signalling pathway in adipocytes [19]. The activity
and expression of System L1 in adipocytes, and its regulation
by TH, may therefore be of quantitative importance for
whole body iodothyronine and amino acid turnover. In the
present study using diﬀerentiated 3T3-L1 mouse adipocytes
[20, 21], we investigate how the mechanism of System L1
transport is inﬂuenced by iodothyronines.
2.ExperimentalProcedures
2.1. Materials. L-[2,3,4,5,6-3H]Phenylalanine was obtained
from Amersham (GE Healthcare, Slough, U.K.) and L-
[125I]-Triiodothyronine from PerkinElmer (Bucks, UK). Cell
culture media were obtained from GibcoBRL Life Technolo-
gies (Paisley, UK) unless stated otherwise; other chemicals2 Journal of Thyroid Research
were obtained from either Sigma Chemicals (Poole, Dorset,
UK) or BDH Merck Ltd (Poole, Dorset, UK).
2.2. Cell Culture. 3T3-L1 mouse ﬁbroblasts (ATCC CL-173)
were cultured at 37◦C, 95% air: 5% CO2 in Dulbecco’s
Modiﬁed Eagles Medium (DMEM; high-glucose) with 10%
Donor Bovine Serum (DBS) and 1% antibiotic/antimycotic
(A/A) solution. Before reaching conﬂuence, cells were resus-
pended by trypsinisation and reseeded into 6- or 12-well
experimental plates. To diﬀerentiate into adipocytes [22],the
3T3-L1ﬁbroblastsweregrowntoconﬂuence(preadipocytes)
and then the medium was changed to DMEM with 10%
foetal bovine serum (FBS) and 1% A/A solution over the
duration of the diﬀerentiation process. For the ﬁrst two days
of diﬀerentiation, 1μg·mL−1 insulin, 5μM isobutylmethylx-
anthine, and 100pM dexamethasone were also added to
the media and for the subsequent two days 1μg·mL−1
insulin alone was added. The adherent cells were allowed
to fully diﬀerentiate over a further six days, then used for
e x p e r i m e n t so nd a y s1 1o r1 2 .
2.3. [125I]-T3 and [3H]Phenylalanine Uptakes. Immediately
prior to an experiment, media was aspirated from the wells
and the cells were washed twice in PBS. Transport buﬀer
(121mM NaCl, 4.9mMKCl, 2.5mMMgSO4,2 0 m MT r i s -
HCl, 1mMCaCl2, pH 7.4) containing either L-[125I]-T3 at
30kBq·mL−1 or L-[3H]phenylalanine at 18.5kBq·mL−1 and
any other necessary compounds (e.g., inhibitors) were then
added to the cells. Once the cells had been incubated in
the transport buﬀer for the designated time period, the
buﬀer was aspirated and the cells were washed quickly
three times in cold PBS to halt the uptake process. The
cells were then lysed in 1.25mL 50mM NaOH overnight at
room temperature prior to assay of radioactivity by liquid
scintillation counting and determination of protein concen-
tration using Bradford reagent (Biorad UK). Preliminary
experiments (data not shown) demonstrated that the uptake
of 5μM[ 3H]phenylalanine was linear for at least 5 minutes
and therefore, in all subsequent experiments reported here,
phenylalanine uptake was measured over a 3-minute period.
L-[125I]-T3 uptakes were measured over a 10-minute period
[15].Thespeciﬁcactivity(DPM·pmol−1)ofradiotracerswas
calculated from the radioactivity (DPM) of 10μLt r a n s p o r t
buﬀer measured using liquid scintillation counting; tracer
uptake is expressed as pmol·mg protein−1·10min. For trans
stimulation studies, 3T3-L1 adipocytes were preincubated in
transport buﬀer containing 2mM leucine for 15min prior to
the initial PBS washes.
2.4. [3H]Phenylalanine Eﬄux. 3T3-L1 cells were preloaded
with [3H]phenylalanine for a period of 15 minutes according
to the uptake protocol described above. The radioactive
buﬀer was then aspirated oﬀ and the cells were rapidly
washed three times with PBS. The cells were then re-
incubated in (nonradioactive) transport buﬀer, half of which
was removed at timed intervals and immediately replenished
with fresh buﬀer. At the end of each experiment, the
remaining buﬀer was aspirated and the cells lysed overnight
in 1.25mL 50mM NaOH. The incubation buﬀer aliquots
and cell lysates were assayed for radioactivity and the lysate
also for protein concentration as described above.
2.5. RNA Extraction and RT-PCR. RNA was extracted from
cells using TRIzol Reagent (Invitrogen, Poole, UK) according
to the manufacturer’s instructions, resuspended in RNase-
free H2Oa n dq u a n t i ﬁ e db yU Vs p e c t r o m e t r y .1μgR N Aw a s
denatured in the presence of 0.5μg OligodT (Oligo Synthesis
Service, University of Dundee) at 70◦C for 5min then
reverse-transcribed using Moloney Murine Leukemia Virus
Reverse Transcriptase (M-MLV RT) at 100U/μgR N Ai n
25μLr e a c t i o nb u ﬀer including 500μMd N T P s( F e r m e n t a s )
at 42◦C for 1 hour. The resulting ﬁrst-strand cDNA was
stored at −20◦C prior to use in PCR using gene-speciﬁc
primerstotestforspeciﬁcmRNAexpression.Theprimersets
used in the PCR program were
LAT1 forward 5 -tctccttgcccattgtcacc-3 
reverse 5 -atgactcccaggtggtagttcc-3 
LAT2 forward 5 -aagggaacccgacagcgaaacaac-3 
reverse 5 -gggggaagcaggtagggaagagtg-3 .
For each PCR, 2μLo fﬁ r s ts t r a n dD N A ,1μMe a c hp r i m e r
and standard 2x GoTaq Green PCR Master Mix (Promega)
were used in a 20μL total volume. The PCR programme
used was 95◦C, 3min; [94◦C, 30s; 55◦C, 30s; 72◦C, 1min]
40 cycles; 72◦C, 2min using a Thermo Scientiﬁc Hybaid Px2
thermal cycler.
2.6. Data Analysis. The data are expressed as means +/−
S.E.M for n adipocyte preparations. Statistical signiﬁcance
for uptake measurements was assessed by one-way ANOVA
followed by a Dunnet post hoc test. For eﬄux measurements,
Graphpad software (San Diego, CA, USA) was used to
determine whether the gradients of the lines of best ﬁt
(rate constants) were signiﬁcantly diﬀerent from control.
Diﬀerences were considered signiﬁcant where P<. 05.
3. Results
3.1. L-T3 Uptake. T h eu p t a k eo f5 0n ML - [ 125I]-T3 into 3T3-
L1 adipocytes included a substantial saturable component,
being reduced by around 40% on addition of 10uM unla-
belled T3 (Figure 1). The magnitude of this saturable com-
ponent (approximately 1–1.2pmol·mg protein−1·10min−1)
was similar in both adipocytes and pre-adipocytes, although
total uptake was about 50% higher in pre-adipocytes. An
excess of the LNAA leucine (10mM), inhibited over 80%
of saturable T3 uptake (Figure 1). Pre-incubation of 3T3-L1
adipocytes in transport buﬀer containing 2mM leucine for
15 minutes (followed by a rapid wash in PBS) resulted in a
minortransstimulatoryincreaseinsaturable50nML-[125I]-
T3 uptake (by 20 ± 8.5%, n = 3), although this increase did
not reach statistical signiﬁcance.
3.2. Phenylalanine Uptake. The uptake of 5μM phe-
nylalanine into 3T3-L1 cells (0.465 ± 0.065nmol·mgJournal of Thyroid Research 3
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Figure 1: Uptake of the iodothyronine L-T3 into 3T3-L1 adipocytes and pre-adipocytes. [125I]-T3 uptake was measured at 50 nM over 10
minutes in the absence (control) or presence of 10μM unlabelled T3 or 10mM leucine in the uptake buﬀer. Values are expressed ± SEM of
6–12 measurements. ∗P<. 05; value signiﬁcantly diﬀerent from control using Dunnett’s Multiple Comparison Test.
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Figure 2: Eﬀect of amino acids and iodothyronines on uptake of
phenylalanine into 3T3-L1 adipocytes. [3H]phenylalanine uptake
was measured at 5μM over 3 minutes in the absence (control)
or presence of 10μM iodothyronine or 10mM amino acid in the
uptake buﬀer. Values are expressed ± SEM of 3 measurements
(except where indicated) as % of the control ﬂux. ∗∗P<. 01;
value signiﬁcantly diﬀerent from control using Dunnett’s Multiple
Comparison Test.
protein−1·min−1,n = 12) wassaturable,being reducedmore
than 95% by addition of excess (10mM) unlabelled pheny-
lalanine, leucine or BCH (2-aminobicyclo-(2,2,1)-heptane-
2-carboxylic acid; a synthetic System L-type amino acid
transport inhibitor) (Figure 2). 5μM phenylalanine uptake
was also substantially inhibited by T3 and rT3 (82% and 57%
inhibition, resp.) at 10μM, although inhibition by T4 (17%)
and triiodothyroacetic acid (TRIAC; a T3 analogue lacking
theα-aminogrouping)didnotachievestatisticalsigniﬁcance
at this concentration (Figure 2). Saturable phenylalanine
uptake into 3T3-L1 cells had a Km of 31μMa n daVmax of
2.6 ± 0.5nmol·mgprotein−1·min−1 (mean ± sem, n = 6;
see Figure 3). The inhibitory eﬀect of T3 on phenylalanine
uptakealsoappearedtobecompetitive,withaKi oftheorder
of 1-2μM (see Figure 4).
3.3. Phenylalanine Eﬄux. Semilogarithmic plots of the
cumulative loss of preloaded [3H]phenylalanine tracer from
3T3-L1 cells showed that the initial eﬄux was described
by a single rate constant (see Figure 5(a)), indicating that
phenylalanine was released largely from a single, freely
exchangeable intracellular pool. Eﬄux of pre-loaded L-
[3H]phenylalanine from 3T3-L1 adipocytes was trans stim-
ulated in a concentration-dependent manner by external
leucine (Figure 5(a)). Leucine and tryptophan (both System
L substrates) were able to generate over 20 times stimulation
of basal phenylalanine eﬄux (Figure 5(b)). T3 is known
to be a substrate for System L1 amino acid transport,
so we investigated the ability of T3 to trans stimulate
phenylalanine eﬄux. T3 was unable to signiﬁcantly trans
stimulate L-[3H]phenylalanine eﬄux at 10μM( ac o n c e n -
tration approaching the limit of T3 solubility in culture
medium), although it did inhibit the trans stimulatory eﬀect
of 10μM leucine (see Figure 6(a)). rT3 also inhibited the
trans stimulatory eﬀect of 10μM leucine, although T4 did
not to any signiﬁcant degree (Figure 6(a)). The T3 analogue
TRIAC (which does not interact with System L1) had no
eﬀect on either basal or leucine-stimulated phenylalanine
eﬄux. The eﬀect of T3 upon leucine trans stimulated pheny-
lalanine eﬄux was found to be concentration dependent (see
Figure 6(b))w i t h3 . 2 μMT 3 able to inhibit 50% of 10μM
leucine trans stimulated phenylalanine eﬄux, demonstrating
the relatively high aﬃnity of T3 for this interaction.
3.4. Transporter mRNA Expression. We detected mRNA
for LAT1, but not LAT2 (the alternative catalytic subunit4 Journal of Thyroid Research
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Figure 3: Saturable phenylalanine uptake into 3T3-L1 adipocytes. Uptake of [3H]phenylalanine over 3 minutes at 5 diﬀerent phenylalanine
concentrations as indicated (between 1μM and 500μM) was measured. Values are shown ± SEM for 3 measurements in a representative
experiment and are expressed with the nonsaturable component of uptake removed. Figure inset shows a Lineweaver-Burk plot relating
[3H]-phenylalanine uptake (corrected for nonsaturable component) against external phenylalanine concentration. The overall data provide
estimated Km of 31μMa n dVmax of 2.6 ± 0.5nmol·mg protein−1·min−1 (mean ±sem, n = 6).
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Figure 4: Concentration dependence of the inhibitory eﬀect of
tri-iodothyronine on phenylalanine uptake into 3T3-L1 adipocytes.
Uptake of [3H]phenylalanine was measured at 5μMo v e r3m i n u t e s
in the presence of 7 diﬀerent T3 concentrations as indicated
(between 100pM and 10μM). Values are expressed as % of control
phenylalanine uptake (measured in the absence of T3). The dotted
lines indicate that 50% inhibition is achieved with 1.2μMT 3,
estimated as the Ki for T3 inhibition of phenylalanine uptake in
these cells.
producing System L1-type amino acid transport) in 3T3-L1
cells using RT-PCR (see Figure 7).
4. Discussion
3T3-L1 cells in culture are used extensively as an in vitro
model system for studying white adipose tissue [21]a n d
the present results demonstrate that saturable uptake of
the thyroid hormone L-T3 in both pre-adipocytes and
terminally diﬀerentiated 3T3-L1 adipocytes occurs largely by
a mechanism inhibited by the LNAA leucine, a substrate of
the multifunctional System L1 transport system shared by
LNAA and iodothyronines (see [6] for review). Saturable
uptake processes appear to be the predominant routes of
cellular TH entry for genomic signaling viathyroid receptors
in animal cells [7]. There appears to be little change
in functional expression of saturable T3 transport during
adipocyte diﬀerentiation (at least for 3T3-L1 cells), which
is perhaps unsurprising given that T3 is important for the
diﬀerentiation process itself as well as the control of mature
adipocyte functions [10] .T h en o n s a t u r a b l e“ u p t a k e ”o fT 3
into adipocytes includes surface binding (presumably to
secreted lipids and lipoproteins) and partitioning into the
lipid bilayer as well as passive diﬀusion into the cytosol [15].
Transport of phenylalanine (a representative LNAA substrate
for Systems L1, L2 and T) in 3T3-L1 adipocytes conforms
almost exclusively with “classical” System L1-type function
as mediated by LAT1 [23], in that (i) phenylalanine inﬂux
has a Km in the low micromolar range (31μM), (ii) it is
inhibited by BCH and (iii) phenylalanine eﬄux is markedly
trans stimulated in a concentration-dependent manner by
both leucine and tryptophan (consistent with the obligatory
exchange mechanism of System L1 [24]). These features are
clearly distinct from those of other likely contributors to
phenylalanine transport, speciﬁcally because (i) System L2
(LAT3/LAT4) does not recognize tryptophan as a substrate
[25,26],(ii)SystemT(MCT10,originallynamedTAT1)does
not recognize leucine as a substrate [27, 28], and (iii) LAT3,
LAT4, and MCT10 all utilise facilitative diﬀusion rather than
an exchange mechanism [25–27]. Phenylalanine uptake by
3T3-L1cellswascompetitivelyinhibitedbyT3 (Ki of1-2μM)
and rT3 in a manner consistent with expected substrate
interactions for the LAT1 System L1 transporter [29–32].
This strong competitive interaction between iodothyroninesJournal of Thyroid Research 5
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Figure 5: Phenylalanine eﬄux from 3T3-L1 adipocytes. (a) Time
course of phenylalanine eﬄux showing the trans stimulatory eﬀect
of leucine. The cumulative release of [3H]phenylalanine from cells
preloaded with the tracer was measured in the presence or absence
of extracellular leucine over the time period indicated. Values are
shown ± SEM for 6–18 measurements (smaller error bars are
obscured by symbols). C0 represents the cellular radioactivity at the
start of the experiment and Ct is that at time t,a sc a l c u l a t e df r o m
the sum of cumulative radiotracer appearance in the medium and
residual cellular radioactivity. The rate constant for eﬄux was taken
as the gradient of the line of best ﬁt. (b) Eﬀects of external amino
acids on rate constant for phenylalanine eﬄux. Bars indicate rate
constants calculated as described in (a) and error bars represent
SEM for gradient of the line of best ﬁt. ∗P<. 05, ∗∗P<. 01; value
signiﬁcantly diﬀerent from basal value.
and LNAA for transport by System L1 in 3T3-L1 mouse
adipocytes is consistent with our previous studies using
isolated white adipocytes from rats [15], although the
relatively-weak inhibitory eﬀects of T4 in the present study
may reﬂect minor species-speciﬁc diﬀerences in the relative
aﬃnity of diﬀerent TH for LAT1. The Vmax for phenylalanine
transport in 3T3-L1 cells (2.6nmol·mg protein−1·min−1)i s
broadly equivalent to 50pmol·105 cells−1·min−1,av a l u eo f
the same order of magnitude as that measured for System L1
transport in rat adipocytes [15].
Collectively, our results indicate that the Na+-inde-
pendent System L1 transporter contributes substantially to
iodothyronine and LNAA transport in 3T3-L1 adipocytes
and thus for delivery of TH from the plasma to the cytosol,
where ultimately they reach the cell nucleus. System L1 has
been shown to be an important eﬀector of T3 transport in
tissues including placenta and brain as well as adipose ([6]
for review). The LAT1 and LAT2 genes encode for alternative
catalytic protein subunits of System L1 and these function
as heterodimers with 4F2hc/CD98 (see [23] for review).
LAT1 and LAT2 both mediate uptake of iodothyronines as
well as LNAA [30, 31] but while both are expressed in rat
adipocytes [16], it appears that only LAT1 is expressed at
the mRNA level in 3T3-L1 cells. Our transport studies also
indicate the predominant functional expression of LAT1 in
3T3-L1 cells. The Km values obtained for iodothyronine
transport by System L1 are substantially lower than those
measured for LNAA transport, which help T3 especially to
compete eﬀectively with amino acids for transport under
physiological conditions (see [6] for review). High-aﬃnity
receptors for both T4 and T3 have been identiﬁed associated
with the plasma membrane of adipocytes [33] and these
may also facilitate preferential iodothyronine uptake [15]. To
our knowledge, T3 is the most potent natural inhibitor of
System L1 in the mammalian body (and easily surpasses the
widely-used synthetic inhibitor BCH in terms of Ki,i fn o t
speciﬁcity), although Brasilicardin compounds isolated from
bacteria have recently been shown to inhibit with nanomolar
potency [34]. Given the therapeutic potential of System
L1 inhibitors as immunosuppressants and anticancer drugs
[34, 35], it is tempting to suggest that the iodothyronine
skeleton might be used as a template for improved design of
highly speciﬁc, non-TH active, System L1 inhibitors. Reverse
T3but not TRIAC (a T3 analog lacking an amino acid moiety
whichactsasapotentthyroidreceptoragonist)interactswith
System L1 in adipocytes, demonstrating structural speciﬁcity
of System L1 which is clearly distinct from that of nuclear
thyroid hormone receptors. TRIAC selectively stimulates
the metabolic rate of adipose tissue in vivo,af e a t u r e
considered as a potential tool to increase whole body energy
metabolism [13]. It appears from our results that TRIAC
enters adipocytes by a diﬀerent mechanism to T3, which may
help explain why TRIAC administered to rats accumulates in
white adipose tissue even when coadministered with high T3
doses [13].
The bulky T3 molecule has a much reduced Vmax for
transport by System L1 compared to LNAA [30], such
that its speciﬁc interactions with System L1 transport
may competitively inhibit not only inﬂux but eﬄux of6 Journal of Thyroid Research
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Figure 6: Triiodothyronine inhibits the trans stimulatory eﬀect of leucine on phenylalanine eﬄux from 3T3-L1 adipocytes. (a) Eﬀect of
iodothyronines on leucine trans stimulation of phenylalanine eﬄux. Release of preloaded [3H]phenylalanine tracer from cells was measured
in the presence or absence of 10μM leucine ± either T3,T 4,r T 3 or TRIAC (each at 10μM). The rate constants for eﬄux were calculated
as described for Figure 4 and the change in rate constant from control (Δ rate constant) was calculated by subtracting the control eﬄux
(without leucine) from that in the presence of leucine ± iodothyronine/TRIAC. Values are shown ± SEM for 12–18 measurements. ∗P<. 05,
∗∗P<. 01; value signiﬁcantly diﬀerent from control (leucine only) value. (b) Concentration dependence of T3 inhibition of leucine trans
stimulated phenylalanine eﬄux. Release of preloaded [3H]phenylalanine tracer from cells was measured in the presence of 10μM leucine ±
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Figure 7: LAT1, a catalytic subunit for System L1 transport, is expressed in 3T3-L1 adipocytes at the mRNA level but LAT2 is not. Reverse
transcriptase PCR (RT-PCR) using gene-speciﬁc primers designed towards either LAT1 or LAT2 was performed with template cDNA
produced from RNA extracted from 3T3-L1 adipocytes. Samples were separated using 2% agarose alongside a 1kb molecular weight marker
(Roche Applied Science). (a) LAT1 mRNA is expressed in 3T3-L1 adipocytes. Following agarose gel electrophoresis, a band of 150bp was
observed corresponding to the expected PCR amplicon using LAT1-speciﬁc primers as detailed in the text. (b) LAT2 mRNA is not expressed
in 3T3-L1 adipocytes. Following agarose gel electrophoresis, no PCR amplicon was detected when 3T3-L1-derived cDNA was used as a
template. However, PCR using LAT2-specﬁc primers and cDNA derived from rat skeletal muscle did amplify a band of the expected size
(465bp), as shown, which demonstrates the functionality of the primers used.
substrate LNAA by retarding conformational changes of the
transport cycle (note the inhibitory action of T3 on leucine-
induced trans stimulation of phenylalanine eﬄux in 3T3-
L1 cells). Nevertheless, the obligatory exchange mechanism
of the System L1 transporter should allow limited LNAA–
iodothyronine or T4-T3/rT3 exchanges across the adipocyte
plasma membrane and we indeed observed a minor trans
stimulation of saturable L-T3 uptake in 3T3-L1 adipocytes
preincubated with leucine. It is noteworthy in this respect
that adipose tissue in vivo releases small quantities of LNAA
[36]. White adipose tissue depots have the capacity to
deiodinate iodothyronines (especially rT3)[ 37, 38], thus
it is conceivable that regulation of iodothyronine turnover
in fat cells through this pathway would contribute signif-
icantly to modulation of whole body T4-rT3 metabolism,
perhaps particularly in obese individuals. In this respect,
downregulation of iodothyronine uptake by System L1 in
adipocytesinthehypothyroidstate,asreportedpreviouslyin
adipocytes from hypothyroid rats [15], would tend to reduce
the sensitivity of adipose tissue to hormonal activation butJournal of Thyroid Research 7
might help conserve hormone and iodine availability to
other tissues by reducing their degradation in adipose tissue.
Physiological variations in plasma LNAA concentrations,
as occurs during natural feeding cycles, may impact TH
transport and action in adipose (and other tissues where
System L1 is the predominant TH transporter).
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